Newsfeeds Archive - Page 7 of 9

2 minute read

BrainStorm Cell Therapeutics Shares Fall After Updated Biomarker Data From Lead Cell Therapy Candidate

July 7, 8:34 AM

BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) presented new biomarker data from the Phase 3 trial of its late-stage investigational amyotrophic lateral sclerosis (ALS) treatment, NurOwn, at the 2023 ALS and Related Motor Neuron Diseases

BCLI

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

June 20, 1:38 PM

Gainers Evelo Biosciences (NASDAQ:EVLO) shares increased by 49.2% to $0.18 during Tuesday’s regular session. Trading volume for this…

BCLI

11 minute read

Earnings

Earnings Scheduled For May 15, 2023

By Benzinga Insights

May 15, 5:32 AM

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.

AAMC

1 minute read

Earnings

Brainstorm Cell’s Earnings Outlook

By Benzinga Insights

May 12, 10:02 AM

Brainstorm Cell (NASDAQ:BCLI) is set to give its latest quarterly earnings report on Monday, 2023-05-15. Here’s what investors…

BCLI

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

March 31, 1:31 PM

Gainers Bionomics (NASDAQ:BNOX) shares moved upwards by 62.8% to $2.93 during Friday’s regular session. The current volume of…

ANPC

2 minute read

Analyst Ratings

Maxim Group Maintains Buy Rating for Brainstorm Cell: Here’s What You Need To Know

By Benzinga Insights

March 31, 1:00 PM

Maxim Group has decided to maintain its Buy rating of Brainstorm Cell (NASDAQ:BCLI) and lower its price target…

BCLI

4 minute read

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

March 31, 12:47 PM

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

ADN

6 minute read

Earnings

Earnings Scheduled For March 30, 2023

By Benzinga Insights

March 30, 7:24 AM

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

AACG

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

March 29, 1:31 PM

Gainers LogicMark (NASDAQ:LGMK) stock increased by 66.3% to $0.23 during Wednesday’s regular session. The current volume of 81.1…

ARCT

3 minute read

Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 29, 12:50 PM

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.

AGBA